BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Credit Suisse maintains positive on Sun Pharma
The brokerage is positive on Sun Pharma with visibility on growth after Ranbaxy deal. Gleevec settlement and Taro price increase to provide comfort, added Credit Suisse.